Szczepionki AstraZeneca i Pfizer na celowniku. Sypią się pozwy
https://www.medonet.pl/koronawirus,szczepionki-astrazeneca-i-pfizer-na-celowniku-niemieckich-sadow--sypia-sie-pozwy,artykul,06114280.html
Baba Billa NiebieskiEkran wiedziała co robi, rozwodząć się aby uratować kasę.
Niekumaty Bill dał kasę na WHO gdy Donald wycofał, aby zdobyc przychylność i zlecił wyprodukowanie w Indiach wadliwej szczepionki Astra Zeneca, wywołującej zakrzepy i paraliże w całej Europie.
\
Niekumaty minister zdrowia, który nie był medykiem, promował szkodliwą Astra Zenekę, gdy cały zachód już dawno jej zakazał.
Bourla, szef Pfeizera eksperymentował ze swpoja szczepionką w Izraelu, a gdy wykazano, że skutecznośc szczepionki to zaledwie 3 miesiące,
to po propozycji 5.dawki, Izr\aelczycy się zbuntowali i go wygonili
Wojsko iedziało, że jedyna skuteczna szczepionka to autogeniczna , wyprodukowana z koronawirusa ludzkiego przeziębienia i wystarczała 1 dawka i odpornośc została wbudowana w układ immunologiczny na całe zycie.
Wszystkie szczepionki działaja hybrydowo, aktywując układ immunologiczny na inny alergen.
I nadal nie wiadomo, na jakie alergeny aktywowały te wadliwwe szczepionki i za il;e lat pojawi się reakcja anafilaktyczna
Przykładowo, w kryminale weterynarz szczepił 100 lat temu członków rodziny na grypę, ale jadem pszczelim,
a potem wypuszczał jadowite pszczoły, po użądleniu których nastepowała reakcja anafilaktyczna i pacjent się dusił i umierał.
Niech Bill i Bourla zbieraja kasę, bo odszkodowania będą na setki miliardów $$$ za utratę zdrowia, za paraliże, zakrzepice, za zgony
A baza szkodliwych reakcji poszczepiennych, prowadzących do zgonu została udostepniona przez Roberta Kennedy-ego, do publicznego przeglądania i analizy szkodliwości szczepionek na covida
VAERS
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=on&PAGENO=3575&PERPAGE=10&ESORT=&REVERSESORT=&VAX=(COVID19)&DIED=Yes
From the 8/25/2023 release of VAERS data:
Found 35,750 cases where Vaccine is COVID19 and Patient Died
Government Disclaimer on use of this data
Case Details
This is page 3575 out of 3,575
Result pages: prev 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575
VAERS ID: 2675289 (history)
Form: Version 2.0
Age:
Sex: Unknown
Location: Foreign
Vaccinated: 0000-00-00
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -
Administered by: Unknown Purchased by: ?
Symptoms: COVID-19, Oxygen saturation, PaO2/FiO2 ratio, Respiratory rate, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: SpO2; Result Unstructured Data: Less than 94% on room air at sea level; Test Name: PaO2/FiO2; Result Unstructured Data: ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) was less than
300 mm Hg; Test Name: respiratory rate; Result Unstructured Data: More than 30 breaths/min; Test Name: PCR- confirmed COVID-19; Test Result: Positive
CDC Split Type: KRMODERNATX, INC.MOD20237
Write-up: Deceased with covid-19 infection; This literature-non-study case was reported in a literature article and describes the occurrence of COVID-19 (Deceased with covid-19 infection) in a patient of an unknown age and gender who received mRNA-1273 (
Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient
experienced COVID-19 (Deceased with covid-19 infection) (seriousness criteria death and hospitalization). The reported cause of death was covid-19 infection. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS (normal ranges are provided in
parenthesis if available): On an unknown date, Oxygen saturation: Less than 94% on room air at sea level. On an unknown date, PaO2/FiO2 ratio: ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) was less than 300 mm Hg.
On an unknown date, Respiratory rate: More than 30 breaths/min. On an unknown date, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the
reporter did not provide any causality assessments. No concomitant medications were reported. This study aimed to compare nAb levels in various vaccine recipients and patients. Vaccine recipients were enrolled from September 2021 to December 2021, and
patients were enrolled from June 2021 to March 2022. All vaccine recipients showed negative results in the COVID-19 polymerase chain reaction (PCR) test. Blood samples from the recipients were collected one month after the last injection. COVID-19
patient group was defined as patients who were hospitalized due to severe COVID-19 during study period. The patient group consisted of 46 patients with PCR confirmed COVID-19 who were admitted to the hospital for intensive care and met the criteria for
severe illness. Lung infiltrates was $g 50%. Of the deceased patients who had received vaccination, 2 had been administered the BNT vaccine, 1 had received the AZ vaccine, and 1 had received the Moderna vaccine (mRNA-1273). It was concluded that
heterologous booster vaccination after primary vaccination produces higher nAb titers and provides a higher level of protection against the omicron variant compared to primary vaccination alone. This protective effect was similar to that observed in
patients with severe COVID-19. No treatment medications were reported. Company Comment: This is a literature non-study case concerning a patient of unknown age and gender with no reported medical history, who experienced the serious (due to Fatal and
Hospitalization) unexpected event of COVID-19. The event occurred on an unknown date after a dose of mRNA-1273 vaccine. The patient presented the criteria for severe illness: SpO2 < 94% on room air at sea level, ratio of arterial partial pressure of
oxygen to fraction of inspired oxygen (PaO2/FiO2) < 300 mm Hg, respiratory rate $g 30 breaths/min, or lung infiltrates $g 50%. Clinical course, supportive diagnostic procedures and treatment were not provided. The outcome of the event was reported as
fatal. The reported cause of death was covid-19 infection. It is unknown if an autopsy was performed. The event was considered as not related to the vaccine based on infectious etiology; the current pandemic outbreak is an alternative explanation for the
event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2023: Follow up received by safety on 18-AUG-2023, contains significant information.
Literature information, product and event details updated. Narrative updated.; Reported Cause(s) of Death: Covid-19 infection
VAERS ID: 2675615 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 2021-06-24
Onset: 2021-09-14
Days after vaccination: 82
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC5436 / 2 - / OT
Administered by: Other Purchased by: ?
Symptoms: Diffuse large B-cell lymphoma
SMQs:, Malignant lymphomas (narrow), Haematological malignant tumours (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2675766 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 2022-08-11
Onset: 2023-07-07
Days after vaccination: 330
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FP1515 / UNK - / OT
Administered by: Other Purchased by: ?
Symptoms: Diffuse large B-cell lymphoma
SMQs:, Malignant lymphomas (narrow), Haematological malignant tumours (narrow)
Life Threatening? Yes
Birth Defect? No
Died? Yes
Date died: 2023-07-01
Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2675778 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 2022-12-06
Onset: 2023-01-21
Days after vaccination: 46
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 4 - / -
Administered by: Other Purchased by: ?
Symptoms: Cerebral infarction, Interchange of vaccine products, SARS-CoV-2 test SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Medication errors (broad), COVID-19 (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2023-01-21
Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2675793 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 0000-00-00
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -
Administered by: Other Purchased by: ?
Symptoms: Death
SMQs:
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: JPPFIZER INCPV20230014134
Write-up: The patient died; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. A 73-year-old female patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) for
covid-19 immunisation. The patient''s relevant medical history and concomitant medications were not reported. The patient died after receiving the first dose of vaccine. Two days after the vaccination, sudden change was observed at home, and she was
transported to the hospital. The event "the patient died" required physician office visit. The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about
lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: The patient died
VAERS ID: 2675794 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 2022-12-13
Onset: 2022-12-14
Days after vaccination: 1
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH GJ7139 / 5 - / OT
Administered by: Other Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, Cardio-respiratory arrest, Heart rate, Pulmonary venous thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic
events, venous (narrow), Acute central respiratory depression (broad), Respiratory failure (broad), Noninfectious myocarditis/pericarditis (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2022-12-14
Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: TAKECAB; CARVEDILOL TEVA; FLUITRAN [TRICHLORMETHIAZIDE]; CILOSTAZOL; BEOVA; CAMSHIA; FEBURIC; TRIAZOLAM; ENBREL; BONALON
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Bladder cancer (transurethral tumour resection for bladder cancer in 2015); Breast cancer; Hypertension; Oophorectomy (for ovarian cancer); Osteoporosis; Ovarian cancer (total hysterectomy-
oophorectomy for ovarian cancer in 1991); Overactive bladder; Reflux oesophagitis; Rheumatism; Rheumatoid arthritis; Total hysterectomy (for ovarian cancer); Tumour excision (for bladder cancer)
Allergies:
Diagnostic Lab Data: Test Date: 20221128; Test Name: blood pressure; Result Unstructured Data: Test Result:148/77; Test Date: 20221128; Test Name: body temperature; Result Unstructured Data: Test Result:36.2 Centigrade; Test Date: 20221128; Test Name:
pulse; Result Unstructured Data: Test Result:96 beats
CDC Split Type: JPPFIZER INCPV20230014330
Write-up: Pulmonary venous thrombosis; Cardio-respiratory arrest; This is a spontaneous report received from a contactable reporter(s) (Physician). An 80-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (COMIRNATY RTU FOR BA.4-5), on
13Dec2022 as dose 5 (booster), 0.3ml single (Lot number: GJ7139, Expiration Date: 31Jul2023) intramuscular for covid-19 immunisation. The patient''s relevant medical history included: "Hypertension" (unspecified if ongoing); "Reflux oesophagitis" (
unspecified if ongoing); "overactive bladder" (unspecified if ongoing); "rheumatism" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "ovarian cancer" (unspecified if ongoing), notes: total hysterectomy-oophorectomy for ovarian cancer
in 1991; "breast cancer", start date: 2006 (unspecified if ongoing); "bladder cancer" (unspecified if ongoing), notes: transurethral tumour resection for bladder cancer in 2015; "Rheumatoid arthritis" (unspecified if ongoing); "total hysterectomy-
oophorectomy", start date: 1991, stop date: 1991, notes: for ovarian cancer; "total hysterectomy-oophorectomy", start date: 1991, stop date: 1991, notes: for ovarian cancer; "transurethral tumour resection", start date: 2015, stop date: 2015, notes: for
bladder cancer. The history of present illness is as follows: Hypertension: The patient had already taken antihypertensive agents when she made the first visit to the clinic, so the start timing of treatment is unknown. The systolic blood pressures
fluctuated by the administration of medications which were described separately but were well-controlled at mostly about 120 to 130. No arrhythmia was observed. Reflux oesophagitis: The symptom was recovering by prescription of PPI. Overactive bladder:
The symptom was recovering with beta agonists. From 28Nov2022, the treatment was switched from BETANIS to BEOVA. Rheumatoid arthritis: In Oct2018, treatment was started at the department of orthopedic surgery of privacy Central Hospital. At the beginning,
the patient was treated with PREDONINE 5 mg and RHEUMATREX 4c/day. From Jul2019, the patient underwent ENBREL for Injection only at our clinic once a week. The patient underwent the last injection at our clinic on 12Dec2022. For more details on the
disease status, please ask privacy Central Hospital. Osteoporosis: From Nov2016, the patient started receiving BONALON for I.V. Infusion once a month. The patient received the last I.V. Infusion. On 28Nov2022 (Monday), the patient took the following
medications: TAKECAB Tablets 10 mg, 1 tablet, oral; Carvedilol Tablets 10 mg "TEVA" 1 tablet, oral; FLUITRAN Tablets 1 mg, 1 tablet QD after breakfast (oral) for 28 days; Cilostazol Tablets 100 mg "NICHI-IKO", 2 tablets, b.i.d. after breakfast/dinner (
oral) for 28 days; BEOVA Tablets 50 mg, 1 tablet, oral; CAMSHIA COMBINATION TABLETS HD "NIPRO", 1 tablet, oral; FEBURIC Tablets 10 mg, 1 tablet, QD after dinner (oral) for 28 days; Triazolam Tablets 0.25 mg "NICHI-IKO", 0.5 tablets, QD, before bedtime (
oral) for 28 days; ENBREL 50 mg PEN 1.0 mL for S.C. Injection, 1 mL 1 kit (start date: Jul2019, stop date: 12Dec2022); BONALON Bag for I.V. Infusion 900 ug 100 mL, 1 bag (start date: Nov2016, stop date: 28Nov2022). Vaccination history included: coviD-19
vaccine (dose 1, unknown manufacturer), administration date: 01Jun2021, for COVID-19 immunisation, reaction(s): "did not experience abnormal adverse reactions at all"; Covid-19 vaccine (dose 2, unknown manufacturer), for COVID-19 immunisation, reaction(s)
: "did not experience abnormal adverse reactions at all"; Covid-19 vaccine (dose 3, unknown manufacturer), for COVID-19 immunisation, reaction(s): "did not experience abnormal adverse reactions at all"; Covid-19 vaccine (dose 4, unknown manufacturer),
for COVID-19 immunisation, reaction(s): "did not experience abnormal adverse reactions at all". Clinical course: On 14Dec2022 (2 days after vaccination), the patient experienced Cardio-respiratory arrest and Pulmonary venous thrombosis. On the day after
the fifth vaccination, the patient was found in a state of cardio-respiratory arrest after having breakfast. The patient was transported to the hospital by ambulance but died. According to the diagnosis by the medical examiner, the cause of death was
pulmonary venous thrombosis. Judicial autopsy was not performed. At the request of the bereaved family, the reporter wrote a reference letter for the Relief System for Sufferers from Adverse Drug Reactions (ADR) (see the attachment). Reference letter: I
medically examined the patient for the first time on 30Jul2016. For the following disease names, I had prescribed oral drugs and had given injections as a primary care physician. The patient received all doses of COVID-19 vaccine from the first dose on
01Jun2021 to the fifth dose on 13Dec2022 at our clinic. The patient did not experience abnormal adverse reactions at all. After the vaccination on 13Dec2022, the patient underwent the 15-minute observation on disease status as usual and was assessed as
no problem and went home. The patient had a past medical history of total hysterectomy-oophorectomy for ovarian cancer in 1991, breast cancer in 2006, and transurethral tumour resection for bladder cancer in 2015. I performed the last medical examination
before the vaccination on 28Nov2022 and confirmed the patient''s blood pressure [148/77], pulse [96] beats, and body temperature [36.2] degrees Celsius, without any special complaints. On 14Dec2022, the outcome of Cardio-respiratory arrest and Pulmonary
venous thrombosis was fatal. The reporter classified the events (Cardio-respiratory arrest and Pulmonary venous thrombosis) as serious (death, death date: 14Dec2022, Cause of Death: Pulmonary venous thrombosis).; Sender''s Comments: The causal
association cannot be excluded between the reported event of fatal pulmonary venous thrombosis and fatal cardiorespiratory arrest based on strong temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is
evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly
notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Cardio-respiratory arrest; Pulmonary venous thrombosis
VAERS ID: 2675795 (history)
Form: Version 2.0
Age: 93.0
Sex: Male
Location: Foreign
Vaccinated: 2021-05-26
Onset: 2021-05-27
Days after vaccination: 1
Submitted: 0000-00-00
Entered: 2023-08-23
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EY5420 / 1 - / -
Administered by: Other Purchased by: ?
Symptoms: Altered state of consciousness, Body temperature, Computerised tomogram head, Magnetic resonance imaging head, Seizure
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad),
Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2021-10-17
Days after onset: 143
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 98 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Old cerebral infarction; Symptomatic epilepsy
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210526; Test Name: body temperature; Result Unstructured Data: Test Result:35.7 Centigrade; Comments: before vaccination; Test Date: 20210527; Test Name: head CT; Result Unstructured Data: Test Result:no new cerebral
infarction or cerebral haemorrhage; Test Date: 20210528; Test Name: head MRI; Result Unstructured Data: Test Result:no new cerebral infarction or cerebral haemorrhage
CDC Split Type: JPPFIZER INCPV20230014332
Write-up: status convulsion/convulsion/exacerbation of symptomatic epilepsy; severe consciousness disturbed; This is a spontaneous report received from contactable reporter(s) (Physician) from Regulatory Authority. Regulatory number: v2310000594 (RA). A
93-year and 1-month-old male patient received BNT162b2 (COMIRNATY), on 26May2021 as dose 1, single (Lot number: EY5420, Expiration Date: 31Aug2021) at the age of 93 years for covid-19 immunisation. The patient had old cerebral infarction and symptomatic
epilepsy, and was orally taking antiepileptic drugs as regular medications. The patient took concomitant medications. On 27May2021 at unknown time (2 days after the vaccination), the patient experienced convulsion. The course of the event was as follows:
27May2021 (the day after the vaccination), movement disorder developed. On the same day, the patient was referred and transferred to Medical Association Neurosurgery Center. A head CT on the same day and a head MRI on 28May2021 showed no new cerebral
infarction or cerebral haemorrhage. With a diagnosis of "status convulsion", the patient was admitted to the Center from 27May2021 to 01Sep2021 and received the control of convulsion (medication adjustments). The patient had severe consciousness
disturbed since he was hospitalised, which was unchanged at the time of discharge. On 17Oct2021 (4 months 22 days after the vaccination), the outcome of the Convulsion was fatal. The reporting physician classified the Convulsion as serious (
hospitalization /disability/death) and the causality between the Convulsion and BNT162b2 as unassessable. The events were also considered medically significant. Other possible cause of the event, such as any other disease, was the exacerbation of
symptomatic epilepsy, which was the patient''s pre-existing condition. The reporting physician commented as follows: Starting on the day after the vaccination, the exacerbation of symptomatic epilepsy (the patient''s chronic illness) occurred. Causal
relationship with the vaccine is unknown.; Reported Cause(s) of Death: status convulsion/convulsion/exacerbation of symptomatic epilepsy; severe consciousness disturbed
VAERS ID: 2675882 (history)
Form: Version 2.0
Age: 85.0
Sex: Female
Location: Foreign
Vaccinated: 2023-06-05
Onset: 2023-07-16
Days after vaccination: 41
Submitted: 0000-00-00
Entered: 2023-08-24
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 5 - / -
Administered by: Unknown Purchased by: ?
Symptoms: Abdominal pain, Acute kidney injury, Amylase, Antibody test, Blood fibrinogen, Blood pressure measurement, Body temperature, C-reactive protein, Computerised tomogram, Fibrin D dimer, Gastric ischaemia, Gastrointestinal necrosis, Hypoperfusion,
Pancreatitis necrotising, Prothrombin time, Tachycardia, Thrombin time, Ultrasound abdomen, Vomiting
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Acute pancreatitis (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal
fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/
anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (narrow), Tumour lysis syndrome (broad), Drug reaction with
eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2023-07-17
Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2676026 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 0000-00-00
Onset: 2022-10-28
Submitted: 0000-00-00
Entered: 2023-08-24
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 4 - / -
Administered by: Other Purchased by: ?
Symptoms: Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2022-10-28
Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2676106 (history)
Form: Version 2.0
Age:
Sex: Unknown
Location: Foreign
Vaccinated: 0000-00-00
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2023-08-24
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -
Administered by: Other Purchased by: ?
Symptoms: Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: TRPFIZER INC202300282413
Write-up: died of heart attacks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from License Party. The reporter is the patient. Other Case identifier(s): 009651, TR-BNTAG-005330. A patient (no qualifiers
provided) received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient''s relevant medical history and concomitant medications were not reported. The following information was reported:
MYOCARDIAL INFARCTION (death, medically significant), outcome "fatal", described as "died of heart attacks". The patient date of death was unknown. Reported cause of death: "Heart attack". Reporter Comment: from MOP via social media: "Nowadays there are
more and more cases of heart attacks, and based on my observations, usually people in the age group of 60 die... If there is a death every day, then the link between heart attacks and the carbon residues that are said to be injected into our bodies with
vaccines should be investigated. Is there a link between the flight of Biontech Vaccine owners from specific country and the compensation lawsuits of citizens? The relatives of other citizens who died of heart attacks will contribute to revealing this
scientific reality through lawsuits they will file. Since there are no universities. The work is left to the courts again...Those who are victimized by the deaths of their loved ones who have been buried in the black soil, please seek your rights. We
cannot bring back the dead, but if chemical and biological weapons in lands are making us swallow massacres as normal deaths, this is not fate...It is a tactical practice. 1- Submit a petition to the court stating that I request the determination of the
event that triggered the heart attack and ask the following issues from the authority. -Determination of the amount of carbon in the body together with its modified derivatives. -If any, the effect of carbon and its traces on vasodilation and
constriction, and whether it can be influenced by remote sound, image and light. -Whether the risk of the Biontech Vaccine is known or not, if it is known, whether the consent of the vaccine candidate has been taken based on my ignorance and why it has
been taken. -Determination of the number of doctors in the country and the number of doctors who have been vaccinated during the pandemic. -The reason and justification for the escape of the Biontech company from specific country to be asked from the
Attache. -to determine together with the immediate family whether the deceased had a history of heart disease. -Requesting from all relevant units how the practices and rules of the administration, which takes measures to enforce vaccination, are
implemented. -I request the hospital to determine whether the injected liquid, together with all the materials and the ratio of the injected liquid and the way it is excreted from the body and whether it is possible." No further information is expected.
No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. SUSPECT PRODUCT is under agreement with BIONTECH SE; Reporter''s Comments: from MOP via social media: "The relatives of
citizens who died of heart attacks will contribute to revealing this scientific reality through lawsuits they will file. Since there are no universities. The work is left to the courts again...Whether the risk of the Biontech Vaccine is known or not, if
it is known, whether the consent of the vaccine candidate has been taken based on my ignorance and why it has been taken.; Reported Cause(s) of Death: Heart attack
Result pages: prev 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575
New Search
Link To This Search Result:
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3575&VAX=COVID19&DIED=Yes
Copyright © 2023 National Vaccine Information Center. All rights reserved. 21525 Ridgetop Circle, Suite 100, Sterling, VA 20166
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)